Siemens to Supply ¹⁸F Sodium Fluoride Nationwide through PETNET Solutions

March 5, 2010

Knoxville, Tenn., March 5, 2010 - PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, Inc. announced today that it is prepared to distribute, on a national basis, ¹⁸F-sodium fluoride (¹⁸F-NaF) through its network of 47 PET radiopharmacies in the U.S.

PETNET to Supply ACRIN Multicenter Trial Network

October 30, 2009

Knoxville, Tenn., October 30, 2009 - PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions, announced today that it is a registered supplier of ¹⁸F-sodium fluoride (18F-NaF) and investigational 3'Deoxy-3'[18F] Fluorothymidine (18F-FLT) to the American College of Radiology Imaging Network (ACRIN) in support of ACRIN's multi-center clinical trials.

Study Offers Hope for Advancement in Cancer Diagnosis and Treatment

September 23, 2009

Montreal, Canada, Sept. 23, 2009 - Siemens Healthcare announced today the initial findings of a new imaging biomarker developed by its molecular imaging biomarker research facility in collaboration with Dr. Jian Q. (Michael) Yu and Fox Chase Cancer Center in Philadelphia. The new imaging agent was designed to capture and quantify the cellular expression of CA-IX, an enzyme whose expression has been linked to tumor growth and invasion, as well as hypoxia. The results were presented today at the World Molecular Imaging Conference in Montreal.

PETNET to Supply SNM Multicenter Trial Network

July 17, 2009

Knoxville, Tenn., July 17, 2009 - PETNET Solutions, a wholly owned subsidiary of Siemens Medical Solutions USA, Inc. announced today that they are a registered supplier of investigational 3'Deoxy-3'[18F] Fluorothymidine (F-18 FLT) to the Society of Nuclear Medicine's Clinical Trial network. This was made possible via a cross reference from Siemens Molecular Imaging/PETNET's Drug Master File (DMF) to the SNM's centralized IND.

PETNET Solutions Signs Supply Agreement with Lantheus Medical Imaging

June 11, 2009

Toronto, Canada, June 11, 2009 - PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, Inc., and a leader in radiopharmaceutical manufacturing and distribution, has announced the execution of a supply agreement with Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, to provide BMS747158 for PET imaging of cardiac perfusion as part of the Phase II and Phase III trials. PETNET Solutions/Siemens has previously supplied all of the clinical trial doses for the Lantheus Phase I study. BMS747158 is Lantheus' novel fluorine 18-labeled Positron Emission Tomography (PET) tracer for myocardial perfusion imaging in subjects under rest and stress conditions.

PETNET Prepared to Address NaF Production Shortages

June 10, 2009

Knoxville, Tenn., June 5, 2009 - PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, Inc., has reported that it is prepared to increase production and availability of 18F Sodium Fluoride (NaF) to replace Technetium for MDP bone scans. The company has taken appropriate steps to help offset shortages of molybdenum, which can result in limited availability of 99mTc-labeled radiopharmaceuticals.

PETNET Solutions Opens North Carolina SPECT Radiopharmacy

March 20, 2009

Knoxville, Tenn., March 20, 2009 - PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, Inc. and a leader in radiopharmaceutical distribution, has announced the opening of a new SPECT radiopharmacy in Raleigh, N.C. Through an agreement with Covidien Medical Imaging, PETNET now offers a combined portfolio of high energy and low energy radioisotopes to the nuclear medicine community, further expanding its PET and single photon emission computed tomography (SPECT) coverage.

Siemens PETNET Solutions, Covidien Enter Co-Marketing Agreement

November 3, 2008

Hoffmann Estates, Ill., Nov. 3, 2008 - PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, Inc. and a leader in radiopharmaceutical distribution, and Covidien, a leading global provider of healthcare products, jointly announce they have entered into a co-marketing agreement to offer a combined portfolio of high-energy and low-energy radioisotopes to the nuclear medicine community in the United States.

Siemens’ PETNET Solutions Poised to Assist During Moly Shortage

October 3, 2008

Malvern, Pa., October 3, 2008 – The recent shortage of Molybdenum has caused a temporary shortage of ^99mTc-labeled radiopharmaceuticals and may continue over the next several weeks. PETNET Solutions, a fully owned subsidiary of Siemens Medical Solutions USA Inc., is prepared to increase production and availability of ¹⁸F Sodium Fluoride (NaF) to replace Technetium MDP bone scans.

Siemens Strengthens Position in Biomarker Production and Research

June 16, 2008

NEW ORLEANS, La., June 16, 2008 – To help ensure that more healthcare facilities throughout the United States have access to the positron emission tomography•computed tomography (PET•CT) technology that helps clinicians diagnose and treat disease earlier and more effectively, Siemens Healthcare (www.siemens.com/healthcare) has opened two new radiopharmacies in Las Vegas and Pittsburgh.

Siemens to Launch PETNET Services in India

March 26, 2008

HOFFMAN ESTATES, Ill., March 26, 2008 – Siemens Healthcare (www.siemens.com/healthcare) today announced its first molecular imaging biomarker production facility in Chennai, India. The new facility will enable the healthcare providers in and around Chennai to access the positron emission tomography•computed tomography (PET•CT) technology to diagnose patients with life-threatening diseases, such as cancer and cardiac and neurological ailments. With this facility, Siemens makes another investment in strengthening critical healthcare infrastructure in the country to elevate the level of available healthcare services.